Shortcuts from other journals

Oral vaccine protects European infants from rotavirus gastroenteritis

BMJ 2007; 335 doi: 10.1136/bmj.335.7630.1119 (Published 29 November 2007)
Cite this as: BMJ 2007;335:1119.1

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Rotarix is GlaxoSmithKline's oral vaccine against rotavirus infections. It worked well in Latin America, and the company has now completed a large phase III trial in nearly 4000 infants in Europe. Two doses of the vaccine given with other routine vaccinations reduced rotavirus …

Access to the full text of this article requires a subscription or payment

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL